BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2822297)

  • 1. Malignant somatostatinoma presenting with diabetic ketoacidosis.
    Jackson JA; Raju BU; Fachnie JD; Mellinger RC; Janakiraman N; Lloyd RV; Vinik AI
    Clin Endocrinol (Oxf); 1987 May; 26(5):609-21. PubMed ID: 2822297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic somatostatinoma: presentation with recurrent episodes of severe hyperglycaemia and ketoacidosis.
    Willcox PA; Immelman EJ; Barron JL; Klaff LJ; Harries-Jones EP; Hainsworth M; Millar RP
    Q J Med; 1988 Jul; 68(255):559-71. PubMed ID: 2855274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant somatostatinoma presenting with diabetic ketoacidosis and inhibitory syndrome: pathophysiologic considerations.
    Theodoraki A; Khoo B; Hamda A; Grillo F; Meyer T; Bouloux PM
    Endocr Pract; 2010; 16(5):835-7. PubMed ID: 20497932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal somatostatinoma associated with diabetic ketoacidosis presumably caused by somatostatin-28 hypersecretion.
    Kim DM; Ahn CW; Kim KR; Hong SW; Nam MS; Cha BS; Lim SK; Lee HC; Lee EJ
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6310-5. PubMed ID: 16105971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A somatostatin-secreting cell line established from a human pancreatic islet cell carcinoma (somatostatinoma): release experiment and immunohistochemical study.
    Iguchi H; Hayashi I; Kono A
    Cancer Res; 1990 Jun; 50(12):3691-3. PubMed ID: 1971195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pancreatic somatostatinoma in a patient with dermatitis herpetiformis and coeliac disease.
    Levi S; Bjarnason I; Swinson CM; Polak JM; Murray W; Levi AJ
    Digestion; 1988; 39(1):1-6. PubMed ID: 2899527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic ketoacidosis as first manifestation of a metastasic somatostatinoma].
    Prieto Tenreiro AM; Díaz Guardiola P
    Med Clin (Barc); 2011 Jan; 136(1):39-40. PubMed ID: 19822331
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoid syndrome due to a malignant somatostatinoma.
    Ozbakir O; Keleştimur F; Oztürk F; Sözüer E; Unal A; Patiroğlu TE; Güven K
    Postgrad Med J; 1995 Nov; 71(841):695-8. PubMed ID: 7494779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of somatostatinoma: responses to food and SMS 201-995 administration.
    Davis TM; Bray G; Domin J; Bloom SR
    Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant somatostatinoma--diagnosis after 6 years].
    Schaller P; Schweiger M; Stolte M; Lauer E
    Leber Magen Darm; 1990 May; 20(3):152-6. PubMed ID: 1974023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
    Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic somatostatinoma.
    Kelly TR
    Am J Surg; 1983 Nov; 146(5):671-3. PubMed ID: 6314830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.
    Schusdziarra V; Grube D; Seifert H; Galle J; Etzrodt H; Beischer W; Haferkamp O; Pfeiffer EF
    Klin Wochenschr; 1983 Jul; 61(14):681-9. PubMed ID: 6136627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic production of somatostatin-like immuno- and bioactivity by cultured human pulmonary small cell carcinoma.
    Szabo M; Berelowitz M; Pettengill OS; Sorenson GD; Frohman LA
    J Clin Endocrinol Metab; 1980 Nov; 51(5):978-87. PubMed ID: 6106652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatinoma of the cystic duct.
    Goodman ZD; Albores-Saavedra J; Lundblad DM
    Cancer; 1984 Feb; 53(3):498-502. PubMed ID: 6318950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal somatostatinoma with psammoma bodies.
    Albrecht S; Gardiner GW; Kovacs K; Ilse G; Kaiser U
    Arch Pathol Lab Med; 1989 May; 113(5):517-20. PubMed ID: 2565711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
    Patel YC; Ganda OP; Benoit R
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentagastrin and glucagon stimulate serum somatostatin-like immunoreactivity in man.
    Epstein S; Berelowitz M; Bell NH
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1227-31. PubMed ID: 6108330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatinoma--the most recently described pancreatic islet cell tumor.
    Reynolds C; Pratt R; Chan-Yan C; Boyko W; MacDonald W; Schmidt N; Rudland R
    West J Med; 1985 Mar; 142(3):393-7. PubMed ID: 2859702
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatinoma syndrome: does a clinical entity exist?
    Stacpoole PW; Kasselberg AG; Berelowitz M; Chey WY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):80-7. PubMed ID: 6297217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.